5 Key Drug Approvals and CRLs in 2024
Among the many FDA decisions in 2024, some stood out more than others. Among the approvals were some surprising—and not-so surprising—complete response letters (CRLs). In addition, some biologics gained new biosimilars with interchangeability designations, …